Actively Recruiting
Analysis of Biomarkers From Patients With Chorioretinal Diseases
Led by Kyungpook National University Hospital · Updated on 2025-03-06
100
Participants Needed
1
Research Sites
991 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
CONDITIONS
Official Title
Analysis of Biomarkers From Patients With Chorioretinal Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 20 years
- Patients requiring ophthalmologic treatments for decreased visual acuity
- Patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration
- Control patients scheduled for cataract surgery or vitrectomy for nonproliferative posterior segment disorders
You will not qualify if you...
- Under the age of 20 years
- Patients who received anti-vascular endothelial growth factor treatment for proliferative disease before sampling ocular fluid
- Patients who did not sign informed consent
- Patients with intraocular inflammation or infection requiring medication
- Patients with recent eye trauma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dong Ho Park
Daegu, Kyungsangpookdo, South Korea, 700-721
Actively Recruiting
Research Team
D
Dong Ho Park, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here